Back to Search
Start Over
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort
- Source :
- Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid, Consejería de Sanidad de la Comunidad de Madrid
- Publication Year :
- 2017
-
Abstract
- There is little information about the efficacy of active alternative drugs to carbapenems except β-lactam/β-lactamase inhibitors for the treatment of bloodstream infections (BSIs) due to extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E). The objective of this study was to assess the outcomes of patients with BSI due to ESBL-E who received empiric therapy with such drugs (other active drugs [OADs]) or carbapenems.
- Subjects :
- Male
aminoglycosides
therapy
bloodstream infections
Enterobacteriaceae Infections
extended-spectrum β-lactamase–producing Enterobacteriaceae
Bacteremia
Kaplan-Meier Estimate
biochemical phenomena, metabolism, and nutrition
Middle Aged
bacterial infections and mycoses
beta-Lactamases
beta-Lactam Resistance
Anti-Bacterial Agents
Carbapenems
Enterobacteriaceae
polycyclic compounds
bacteria
Humans
Female
antimicrobial resistance
Retrospective Studies
Subjects
Details
- Database :
- OpenAIRE
- Journal :
- Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid, Consejería de Sanidad de la Comunidad de Madrid
- Accession number :
- edsair.RECOLECTA.....781d173a5ff5f36e3c05bec673df1d68